4.7 Article

Vezf1 regulates cardiac structure and contractile function

期刊

EBIOMEDICINE
卷 51, 期 -, 页码 -

出版社

ELSEVIER
DOI: 10.1016/j.ebiom.2019.102608

关键词

Vezf1; Cardiac hypertrophy; Cardiac contractile function; TEAD-1

资金

  1. Helsinki-Uusimaa Hospital District
  2. Academy of Finland [256908, 268505, 297094]
  3. Jane and Aatos Erkko Foundation
  4. Aarne Koskelo Foundation
  5. Finnish Foundation for Cardiovascular Research
  6. Finnish Cultural Foundation
  7. Finnish Foundation for Laboratory Medicine
  8. Finska Lakaresallskapet
  9. Liv och Halsa Foundation

向作者/读者索取更多资源

Background: Vascular endothelial zinc finger 1 (Vezf1) is a transcription factor previously shown to regulate vasculogenesis and angiogenesis. We aimed to investigate the role of Vezf1 in the postnatal heart. Methods: The role of Vezf1 in regulating cardiac growth and contractile function was studied in zebrafish and in primary cardiomyocytes. Findings: We find that expression of Vezf1 is decreased in diseased human myocardium and mouse hearts. Our experimental data shows that knockdown of zebrafish Vezf1 reduces cardiac growth and results in impaired ventricular contractile response to beta-adrenergic stimuli. However, Vezf1 knockdown is not associated with dysregulation of cardiomyocyte Ca2+ transient kinetics. Gene ontology enrichment analysis indicates that Vezf1 regulates cardiac muscle contraction and dilated cardiomyopathy related genes and we identify cardiomyocyte Myh7/beta-MHC as key target for Vezf1. We further identify a key role for an MCAT binding site in the Myh7 promoter regulating the response to Vezf1 knockdown and show that TEAD-1 is a binding partner of Vezf1. Interpretation: We demonstrate a role for Vezf1 in regulation of compensatory cardiac growth and cardiomyocyte contractile function, which may be relevant in human cardiac disease. (C) 2019 The Authors. Published by Elsevier B.V.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据